LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

Search

Quanterix Corp

Închisă

SectorSănătate

4.5 -3.85

Rezumat

Modificarea prețului

24h

Curent

Minim

4.42

Maxim

4.6899999999999995

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+58.9% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-75M

221M

Deschiderea anterioară

8.35

Închiderea anterioară

4.5

Sentimentul știrilor

By Acuity

35%

65%

94 / 351 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 mar. 2026, 22:42 UTC

Câștiguri

Prudential PLC 2025 Adjusted Operating Profit Rises

17 mar. 2026, 21:40 UTC

Câștiguri

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

17 mar. 2026, 23:56 UTC

Market Talk

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

17 mar. 2026, 23:46 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

17 mar. 2026, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 mar. 2026, 23:42 UTC

Market Talk

RBA's Return to Policy Tightening Will Work -- Market Talk

17 mar. 2026, 23:38 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

17 mar. 2026, 23:24 UTC

Market Talk

Global Energy Roundup: Market Talk

17 mar. 2026, 23:24 UTC

Market Talk

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

17 mar. 2026, 22:22 UTC

Market Talk

BHP Hands Reins to Growth-Focused Executive -- Market Talk

17 mar. 2026, 22:20 UTC

Câștiguri

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

17 mar. 2026, 22:20 UTC

Câștiguri

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

17 mar. 2026, 22:07 UTC

Câștiguri

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

17 mar. 2026, 22:05 UTC

Câștiguri

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

17 mar. 2026, 22:04 UTC

Câștiguri

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

17 mar. 2026, 22:03 UTC

Câștiguri

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

17 mar. 2026, 22:01 UTC

Câștiguri

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

17 mar. 2026, 22:01 UTC

Câștiguri

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

17 mar. 2026, 22:01 UTC

Câștiguri

ZTO Express (Cayman) 4Q EPS 47c >ZTO

17 mar. 2026, 21:26 UTC

Câștiguri

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

17 mar. 2026, 21:09 UTC

Câștiguri

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

17 mar. 2026, 21:08 UTC

Câștiguri

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

17 mar. 2026, 21:08 UTC

Câștiguri

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mar. 2026, 21:07 UTC

Câștiguri

Couche-Tard 3Q EPS 82c >ATD.T

17 mar. 2026, 21:06 UTC

Câștiguri

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mar. 2026, 21:05 UTC

Câștiguri

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 mar. 2026, 21:05 UTC

Câștiguri

Couche-Tard 3Q Rev $21.8B >ATD.T

17 mar. 2026, 21:05 UTC

Câștiguri

Couche-Tard 3Q EPS 82c >ATD.T

17 mar. 2026, 21:05 UTC

Câștiguri

Couche-Tard 3Q Net $757.2M >ATD.T

17 mar. 2026, 20:50 UTC

Market Talk
Evenimente importante

Energy & Utilities Roundup: Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

58.9% sus

Prognoză pe 12 luni

Medie 7.5 USD  58.9%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

94 / 351 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat